GeneDx Holdings Corp [WGS] stock prices are up 6.36% to $84.91 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WGS shares have gain 8.38% over the last week, with a monthly amount drifted -5.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on July 09, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $110. Previously, Guggenheim started tracking the stock with Buy rating on May 15, 2025, and set its price target to $88. On May 09, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $80 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $34 on August 28, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $43 as its price target on July 10, 2024.
The stock price of GeneDx Holdings Corp [WGS] has been fluctuating between $25.32 and $117.75 over the past year. Currently, Wall Street analysts expect the stock to reach $42.5 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $84.91 at the most recent close of the market. An investor can expect a potential drop of -49.95% based on the average WGS price forecast.
Analyzing the WGS fundamentals
The GeneDx Holdings Corp [NASDAQ:WGS] reported sales of 330.14M for trailing twelve months, representing a surge of 39.56%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.17 and Total Capital is -0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.87 points at the first support level, and at 76.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 87.07, and for the 2nd resistance point, it is at 89.22.
Ratios To Look Out For
It’s worth pointing out that GeneDx Holdings Corp [NASDAQ:WGS]’s Current Ratio is 3.25. In addition, the Quick Ratio stands at 3.07 and the Cash Ratio stands at 1.43. Considering the valuation of this stock, the price to sales ratio is 7.34, the price to book ratio is 9.41.
Transactions by insiders
Recent insider trading involved Feeley Kevin, CHIEF FINANCIAL OFFICER, that happened on Jul 09 ’25 when 5278.0 shares were sold. Chief Executive Officer, Stueland Katherine completed a deal on Jul 09 ’25 to sell 3220.0 shares. Meanwhile, Chief Executive Officer Stueland Katherine sold 9657.0 shares on Jul 01 ’25.
